Implants signal new way to treat cancer
Cancer patients could be treated more effectively in future with tiny, sensory implants.
The devices, about the size of an eyelash, would be implanted into patients’ tumours, to monitor them in real time and in great detail.
They would allow doctors to target radiotherapy, and ultimately chemotherapy, where and when it is most needed, improving patients’ chances of recovery.
Our aim is, in the long term, help to alleviate suffering and to improve the outlook for very many cancer patients.
The devices will be designed to measure directly vital factors about tumours.
These will include their levels of blood oxygen and key biological molecules, with the information transmitted wirelessly to medical staff.
These readings would enable doctors to identify and target areas of a tumour that are found to be resistant to radiotherapy and drug treatment.
Sensors would also take measurements to indicate how effective the treatment is in killing cancer cells, enabling therapy to be personalised to an individual patient’s cancer.
Doctors would be able to monitor patients’ progress with an unprecedented level of detail.
A team led by the University of Edinburgh, in collaboration with Heriot-Watt University, will develop the miniature chips in a five-year project to prove the technology.
They hope to follow this with clinical trials.
The team also hopes eventually to develop chips that are capable of delivering doses of chemotherapy directly to a tumour.
The £5.2 million project, Implantable Microsystems for Personalised Anti-Cancer Therapy (IMPACT), is funded by the Engineering and Physical Sciences Research Council.
Experts including scientists, engineers, clinicians and social scientists will be working to target cancer, one of the biggest health concerns of today, in an entirely new way.